Literature DB >> 15131563

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

S G O Johansson1, Thomas Bieber, Ronald Dahl, Peter S Friedmann, Bobby Q Lanier, Richard F Lockey, Cassim Motala, Jose A Ortega Martell, Thomas A E Platts-Mills, Johannes Ring, Frank Thien, Paul Van Cauwenberge, Hywel C Williams.   

Abstract

The nomenclature proposed in the October 2003 report of the Nomenclature Review Committee of the World Allergy Organization is an update of the European Academy of Allergology and Clinical Immunology Revised Nomenclature for Allergy Position Statement published in 2001. The nomenclature can be used independently of target organ or patient age group and is based on the mechanisms that initiate and mediate allergic reactions. It is assumed that as knowledge about basic causes and mechanisms improves, the nomenclature will need further review.

Entities:  

Mesh:

Year:  2004        PMID: 15131563     DOI: 10.1016/j.jaci.2003.12.591

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  407 in total

1.  Appropriate allergy testing and interpretation.

Authors:  Jay M Portnoy
Journal:  Mo Med       Date:  2011 Sep-Oct

2.  Anaphylactic and anaphylactoid reactions during the perioperative period.

Authors:  V Lagopoulos; E Gigi
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

3.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 4.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

5.  Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.

Authors:  Roberta Zanotti; Patrizia Bonadonna; Massimiliano Bonifacio; Anna Artuso; Donatella Schena; Maurizio Rossini; Omar Perbellini; Sabrina Colarossi; Marco Chilosi; Giovanni Pizzolo
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

Review 6.  Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of 'atopic dermatitis'.

Authors:  R Kantor; J P Thyssen; A S Paller; J I Silverberg
Journal:  Allergy       Date:  2016-08-03       Impact factor: 13.146

7.  Mechanism of interaction between ocular and nasal neurogenic inflammation in allergic rhinoconjunctivitis.

Authors:  Xiao-Wei Gao; Xiao-Min Zhang; Hai-Yan Liu; Shan-Shan Wang; Hua-Jiang Dong
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

Review 8.  [Drug-induced angioedema : Focus on bradykinin].

Authors:  B Sachs; T Meier; M M Nöthen; C Stieber; J Stingl
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

9.  Low prevalence of hypersensitivity to nonsteroidal anti-inflammatory drugs in Chinese patients with chronic rhinosinusitis.

Authors:  Yingshen Lu; Shuai Li; Lijuan Song; Hui Jin; Yanmei Li; Nanshan Zhong; Xiaowen Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-13       Impact factor: 2.503

Review 10.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.